Newsletter

In our March newsletter we celebrate some exciting updates! Our first products in partnership with StemCultures, and more on the way as we collaborate with Tolemy Bio. We also introduce our new differentiation kits, which contain everything you need for iPSC culture and differentiation.

We're looking forward to what 2025 will bring and would like to wish everyone a very happy and prosperous New Year with our first newsletter of 2025. Featuring new distributors, events and application notes.

In our final newsletter of 2024, we highlight our collaboration with cutting-edge cell-line specialists inscreenex to define TGF beta family activity; celebrate efforts to unite the UK stem cell community and if you are quick, you can benefit from our end-of-year promotion and receive a third free growth factor when you buy two products, a great chance to stock up. 

In this edition, we are excited to announce two new distributor agreements, our products will now be available in Türkiye and SLS will be making our products more accessible in the UK and Ireland. Our latest offer, buy 2 get 1 free and other news, the launch of our high quality food grade range.

In this edition, we are excited to announce a price freeze moving into 2025, our win of Scale-up of the Year in the Cambridge Business Awards. We also share our latest hematopoietic stem cells blog, new products IL-2 and activin E PLUS and a new application note on growth factor stability.

In this edition, we are excited to announce our complete transition to animal origin-free (AOF) manufacturing for all recombinant proteins. This ensures the highest quality and consistency for researchers relying on these critical components. Additionally, discover our latest application notes featuring AOF BDNF and GDNF for neural differentiation and thermostable FGF-2 and TGF-β1 for weekend-free iPSC culture.

In this edition, we are excited to discuss our conversations at ISSCR 2024 about the stem cell science supply chain and impact of growth factors and cytokines quality on reproducibility, including how to integrate new technologies, such as controlled-release and thermostable proteins. We are also pleased to announce our collaboration with the superb team at StemCultures, launch high quality food grade PDGF-BB, publish a new application note focusing on dopaminergic neuron differentiation and welcome to our team Paul Grafham, CFO and Rob Nixon, Commercial Director.

In this edition, we are excited to announce our complete transition to animal origin-free (AOF) manufacturing for all recombinant proteins. This ensures the highest quality and consistency for researchers relying on these critical components. Additionally, discover our latest application notes featuring AOF BDNF and GDNF for neural differentiation and thermostable FGF-2 and TGF-β1 for weekend-free iPSC culture.

In this edition, we are excited to announce our complete transition to animal origin-free (AOF) manufacturing for all recombinant proteins. This ensures the highest quality and consistency for researchers relying on these critical components. Additionally, discover our latest application notes featuring AOF BDNF and GDNF for neural differentiation and thermostable FGF-2 and TGF-β1 for weekend-free iPSC culture.

In this edition, explore our latest data on TGF-beta family proteins designed to facilitate faster optimization of cell culture media. Additionally, you will find other resources to support your research, learn about our upcoming events, and much more.

Welcome to our first newsletter of the year, where we will be highlighting new additions to our portfolio, resources to help your research, our latest promotional offer and upcoming event.

This edition highlights some of our latest resources and products. These include our high-purity mouse/rat Noggin, our newly launched Flt3L (Qk087) to our growing hematopoietic stem cell range and our latest blog on liver organoids emerging as a transformative model for malaria drug discovery.